1- COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). https://coronavirus.jhu.edu/map.html. Accessed July 22, 2020.
2- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi:10.1001/jama.2020.2648
3- Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. 2020; 24:154. https://doi.org/10.1186/s13054-020-02880-z
4- Lang M, Som A, Mendoza DP, Flores EJ, Reid N, Carey D, Li MD, Witkin A, Rodriguez-Lopez JM, Shepard JA, Little BP. Hypoxaemia related to COVID-19: vascular and perfusion abnormalities on dual-energy CT. The Lancet Infectious Diseases. 2020 Apr 30. https://doi.org/10.1016/S1473-3099(20)30367-4
5- Oudkerk M, Büller HR, Kuijpers D, van Es N, Oudkerk SF, McLoud TC, Gommers D, van Dissel J, Ten Cate H, van Beek EJ. Diagnosis, prevention, and treatment of thromboembolic complications in COVID-19: report of the National Institute for Public Health of the Netherlands. Radiology. 2020 Apr 23:201629. https://doi.org/10.1148/radiol.2020201629
6- Thachil, J., and S. Agarwal. Understanding the COVID‐19 coagulopathy spectrum. Anaesthesia 2020. https://doi.org/10.1111/anae.15141
7- Gris JC, Perez-Martin A, Quéré I, Sotto A. COVID-19 associated coagulopathy: the crowning glory of thrombo-inflammation concept. Anaesthesia, Critical Care & Pain Medicine. 2020 May 4. doi: 10.1016/j.accpm.2020.04.013 [Epub ahead of print].
8- Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nature Reviews Immunology. 2013 Jan;13(1):34-45. DOI: 10.1038/nri3345
9- Hansell DM. Small-vessel diseases of the lung: CT-pathologic correlates. Radiology. 2002;225(3):639‐653. doi:10.1148/radiol.2253011490
10- Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, Mehra MR, Schuepbach RA, Ruschitzka F, Moch H. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5.
11- Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, Raizada MK, Grant MB, Oudit GY. Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation research. 2020 May 8;126(10):1456-74. doi: 10.1161/CIRCRESAHA.120.317015
12- Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Science China Life Sciences. 2020 Mar;63(3):364-74. https://doi.org/10.1007/s11427-020-1643-8
13- Zhiyong Wu , Rui Hu, Cuizhen Zhang, Wei Ren, Anfeng Yu and Xiaoyang Zhou. Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients. Crit Care 2020 May 24:290. https://doi.org/10.1186/s13054-020-03015-0
14- Liu P, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020 Apr 15. https://doi.org/10.1161/CIRCULATIONAHA.120.047549
15- Wang K, Gheblawi M, Oudit G. Angiotensin Converting Enzyme 2: A Double-Edged Sword. Circulation. 2020 Mar 26. https://doi.org/10.1161/CIRCULATIONAHA.120.047049
16- Hedenstierna G, Chen L, Hedenstierna M, Scaramuzzo G. Treatment of COVID-19 by Inhaled NO to Reduce Shunt? American Journal of Respiratory and Critical Care Medicine. 2020 Jun 24(ja). https://doi.org/10.1164/rccm.202004-0940LE
17- Gattinoni, L., Chiumello, D. & Rossi, S. COVID-19 pneumonia: ARDS or not?. Crit Care 24, 154 2020. https://doi.org/10.1186/s13054-020-02880-z
18- Coppo A, Bellani G, Winterton D, Di Pierro M, Soria A, Faverio P, Cairo M, Mori S, Messinesi G, Contro E, Bonfanti P. Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study. The Lancet Respiratory Medicine. 2020 Jun 19. DOI:https://doi.org/10.1016/S2213-2600(20)30268-X
19- Polak, S.B., Van Gool, I.C., Cohen, D. et al. A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression. Mod Pathol 2020. https://doi.org/10.1038/s41379-020-0603-3